SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-21-000082
Filing Date
2021-01-25
Accepted
2021-01-25 16:43:09
Documents
2
Group Members
ALEXANDER J. DENNER, PH.D.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13ga.htm SC 13G 50312
2 JOINT FILING AGREEMENT s13gb.htm EX-99.1 3554
  Complete submission text file 0000899140-21-000082.txt   55407
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 21550107
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G